Rapid Micro Biosystems In...

NASDAQ: RPID · Real-Time Price · USD
2.66
-0.16 (-5.67%)
At close: Aug 15, 2025, 12:45 PM

Rapid Micro Biosystems Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
28.05M 22.52M 17.13M 23.23M
Cost of Revenue
28.16M 28M 25.67M 30.97M
Gross Profit
-109K -5.49M -8.54M -7.74M
Operating Income
-49.92M -56.56M -63.22M -47.23M
Interest Income
3.16M 4.21M 1.78M n/a
Pretax Income
-46.87M -52.44M -61.38M -73.43M
Net Income
-46.89M -52.47M -60.81M -73.52M
Selling & General & Admin
35.21M 38.26M 41.81M 29.71M
Research & Development
14.6M 12.82M 12.87M 9.78M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
49.81M 51.08M 54.68M 39.49M
Interest Expense
n/a n/a n/a 2.65M
Selling & Marketing Expenses
13.27M 13.32M 14.99M 11.81M
Cost & Expenses
77.97M 79.08M 80.35M 70.46M
Income Tax Expense
22K 31K -576K 91K
Shares Outstanding (Basic)
43.58M 43.02M 42.45M 41.47M
Shares Outstanding (Diluted)
43.58M 43.02M 42.45M 41.47M
EPS (Basic)
-1.08 -1.22 -1.43 -1.88
EPS (Diluted)
-1.08 -1.22 -1.43 -1.88
EBITDA
-46.56M -53.46M -60.38M -45.8M
EBIT
-49.92M -56.56M -63.22M -47.23M
Depreciation & Amortization
3.36M 3.1M 2.84M 1.63M